Kane Biotech Inc Working Capital to Net Assets Ratio
Kane Biotech Inc working capital to net assets ratio. Kane Biotech Inc (KNE) has a Working Capital to Net Assets ratio of 108.9% as of December 2025. Working capital of CA$-812.62K (current assets of CA$1.69 Million minus current liabilities of CA$2.50 Million) is measured against net assets of CA$-746.54K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Kane Biotech Inc (KNE) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Kane Biotech Inc (2003–2025)
Working capital to net assets ratio of Kane Biotech Inc from 2003 to 2025. This chart shows how Kane Biotech Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the ratio stands at 108.9%, reflecting working capital of CA$-812.62K against net assets of CA$-746.54K CAD. See Kane Biotech Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Kane Biotech Inc Working Capital to Net Assets Ratio by Year (2003–2025)
Kane Biotech Inc working capital to net assets ratio by year from 2003 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Kane Biotech Inc from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see KNE total assets.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 108.9% | CA$-812.62K | CA$-746.54K | CA$1.69 Million | CA$2.50 Million | ▲ +24.1 pp |
| 2024 | 84.8% | CA$-1.38 Million | CA$-1.63 Million | CA$1.03 Million | CA$2.41 Million | ▼ -0.5 pp |
| 2023 | 85.3% | CA$-7.17 Million | CA$-8.41 Million | CA$3.72 Million | CA$10.89 Million | ▲ +6.9 pp |
| 2022 | 78.4% | CA$-3.24 Million | CA$-4.14 Million | CA$3.10 Million | CA$6.34 Million | ▼ -39.0 pp |
| 2021 | 117.5% | CA$-1.84 Million | CA$-1.57 Million | CA$2.88 Million | CA$4.72 Million | ▲ +134.7 pp |
| 2020 | -17.3% | CA$-185.56K | CA$1.07 Million | CA$2.74 Million | CA$2.92 Million | ▼ -85.1 pp |
| 2019 | 67.8% | CA$567.77K | CA$836.81K | CA$1.91 Million | CA$1.34 Million | ▼ -84.8 pp |
| 2018 | 152.7% | CA$-1.50 Million | CA$-984.84K | CA$556.57K | CA$2.06 Million | ▲ +94.6 pp |
| 2017 | 58.1% | CA$1.59 Million | CA$2.74 Million | CA$2.25 Million | CA$659.03K | ▲ +35.7 pp |
| 2016 | 22.4% | CA$301.63K | CA$1.35 Million | CA$1.09 Million | CA$783.72K | ▲ +3.6 pp |
| 2015 | 18.8% | CA$90.08K | CA$480.25K | CA$344.30K | CA$254.21K | ▼ -18.5 pp |
| 2014 | 37.3% | CA$493.71K | CA$1.32 Million | CA$1.16 Million | CA$664.51K | ▼ -17.3 pp |
| 2013 | 54.5% | CA$699.95K | CA$1.28 Million | CA$887.01K | CA$187.06K | ▼ -4.6 pp |
| 2012 | 59.2% | CA$1.39 Million | CA$2.35 Million | CA$1.57 Million | CA$176.73K | ▲ +3.0 pp |
| 2011 | 56.2% | CA$1.34 Million | CA$2.38 Million | CA$1.43 Million | CA$92.72K | ▲ +41.8 pp |
| 2010 | 14.4% | CA$167.46K | CA$1.16 Million | CA$258.21K | CA$90.75K | ▼ -33.0 pp |
| 2009 | 47.4% | CA$852.00K | CA$1.80 Million | CA$920.62K | CA$68.62K | ▲ +6.2 pp |
| 2008 | 41.2% | CA$614.48K | CA$1.49 Million | CA$694.04K | CA$79.56K | ▲ +13.3 pp |
| 2007 | 27.8% | CA$317.49K | CA$1.14 Million | CA$405.35K | CA$87.86K | ▼ -18.7 pp |
| 2006 | 46.6% | CA$663.38K | CA$1.42 Million | CA$756.22K | CA$92.83K | ▲ +15.5 pp |
| 2005 | 31.0% | CA$315.72K | CA$1.02 Million | CA$450.34K | CA$134.62K | ▼ -20.3 pp |
| 2004 | 51.4% | CA$219.19K | CA$426.65K | CA$318.91K | CA$99.72K | ▼ -33.4 pp |
| 2003 | 84.8% | CA$809.82K | CA$955.27K | CA$866.84K | CA$57.02K | — |